Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer
about
Two cycles of cisplatin-based chemotherapy for low-volume stage II seminoma: results of a retrospective, single-center case series.Management of testicular seminoma.Late toxicity following curative treatment of testicular cancer.Clinical characteristics of cutaneous melanoma and second primary malignancies in a dutch hospital-based cohort of cutaneous melanoma patients.Solid tumor risks after high doses of ionizing radiationRadiation-induced skin cancer in humans.Testicular cancer survivorship: research strategies and recommendations.The role of genetic factors in the etiology of pancreatic adenocarcinoma: an update.Stage I seminoma: treatment outcome at King Hussein Cancer Center in Jordan.Clinical and epidemiological features of acute lymphoblastic leukemia following a previous malignancy.Persistence of cisplatin-induced mutagenicity in hematopoietic stem cells: implications for secondary cancer risk following chemotherapyTherapy related leukemias: susceptibility, prevention and treatment.Follow-up surveillance strategies for genitourinary malignancies.DNA topoisomerases participate in fragility of the oncogene RET.Second cancers in patients with neuroendocrine tumors.Pure seminoma: a review and updateBiology of childhood germ cell tumours, focussing on the significance of microRNAs.Epidemiology of renal cell carcinoma.The role of fragile sites in sporadic papillary thyroid carcinomaRecent advances in the treatment of testicular cancer.Postchemotherapy residual masses in advanced seminoma: current management and outcomes.New guidelines for clinical stage I testicular seminoma?Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational researchIncreased mortality rates in young and middle-aged patients with malignant germ cell tumours.Metachronous occurrence of triple malignancies of kidneys, prostate, and breast. A case report and review of the literature.Screening for new primary cancers in cancer survivors compared to non-cancer controls: a systematic review and meta-analysis.Exploration of treatment options for the management of stage I testicular seminoma.Radiation-associated urinary bladder cancer.Bladder cancer in cancer patients: population-based estimates from a large Swedish study.A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects.Management options for stage I seminoma.Complications associated with chemotherapy in testicular cancer management.Diagnosis and management of urothelial carcinoma of the bladder.Management of stage I testicular seminoma over a period of 49 years.Adenocarcinoma of the seminal vesicles complicated by antineutrophil cytoplasmic antibody vasculitis: a case report and review of the literature.A 55-Year-Old Man with Stage IV Squamous Cell Carcinoma of the Right Groin after External Beam Radiation for Testicular Cancer.Pharmacotherapeutic treatment of germ cell tumors: standard of care and recent developments.Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG).Prevention of myelosuppression and genotoxicity induced by cisplatin in murine bone marrow cells: effect of an organovanadium compound vanadium(III)-l-cysteine.Risk of second gonadal cancers in women and children with germ cell tumors.
P2860
Q33405156-E1B8DC0F-C271-4193-8A57-1AE2353F1512Q33788899-5E86B2AD-1F7F-48CD-ADF2-72FDFFA89F8FQ33788925-4B84D887-BBB8-42C5-AAF8-B6960685B021Q33889751-06489ACE-0ADC-4618-8DAA-DB3FDA585D1BQ33941735-7193EA2F-BCD4-4B2D-81DA-0EE3F1A6D047Q33945737-41B6599C-8E85-465C-8F44-9CABF5CAB841Q34039684-0A675E02-7FBB-42D3-B429-44995B8F2A99Q34211033-55EAC9E6-E48A-4EAC-8697-121162A4E44BQ34244316-4A8704A8-A48C-4CB9-8A23-81DBACD4E871Q34244453-0687A52B-379A-4525-A05B-1ECEF423FAD2Q34248313-3549E213-AFB8-4769-A9B9-BC54BD396E83Q34265193-9DF4453F-C8BA-40F5-B5C4-41C44E52706EQ34736606-2E620D12-81D0-4CEF-86B9-7931F9B58D9AQ34990644-BB3A4C66-9355-498A-A362-1D5196EE1B8DQ35083206-752AA693-9BFD-4BA7-B2D9-03C8DE32B903Q35184991-66ED692B-C1F6-44CB-884E-2F8BCDA140D8Q35538367-49484920-7175-42E2-A676-30B70CB4FF5EQ35851652-F543E570-DD4F-44B2-8CBB-17D5BBBC4652Q36063579-93DA085A-7FBD-43B5-AF97-EEABEB52AB5CQ36066174-7D1757D8-4B32-410A-8ED7-D28D703D11B4Q36284519-285B6A60-8751-44DA-9057-B7E6D4DEF681Q36351199-33C841C7-4500-42D9-A1A5-A9BDDF36DCDAQ36535678-9F2747A7-3150-40B0-A5FC-3349C052E875Q36694603-9A8B5AFF-03BB-46F1-9832-42F420E8D214Q36711661-BCDA2484-6225-4318-A419-4157E46780BBQ37072943-3AD6DE09-D140-4E90-90C4-EA42C1E2B732Q37202764-ED1EC4A1-2302-4F6F-BD25-6B7CA97BAE02Q37278975-3FCEE09C-C272-471B-8AA0-A3C8026F0ACCQ37400498-5A2C6D88-E73E-41EB-B62B-3790DE468983Q37482598-65ACC10E-F567-4C68-871A-8C882AAA4FA3Q37774354-988E45D2-FF81-4F45-A4C1-2D76250A868DQ37853021-4758FDE8-E1B6-40E2-8C18-E11D971DDCCBQ37874887-3AB5E7A5-D64D-44D9-AE94-E36587EC9176Q37943902-49A619CB-74B9-4128-8CB9-1F123E6D431BQ38085731-D26C9375-91EC-4193-B474-CEF300D39346Q38229593-AE92A45B-B26F-4334-85B6-D4C4D6C24824Q38656908-626FB181-025A-43BE-822B-3E76DCD86ABEQ38796004-F8C10186-347A-4335-9A1E-F47B636CFD73Q39028505-4ED5A523-15C1-4BE4-93BE-485136168E88Q39789164-CE33F6FB-895E-43F4-AA82-3B930125C48A
P2860
Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer
description
im Oktober 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 October 1997
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 1997
@uk
name
Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer
@en
Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer
@nl
type
label
Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer
@en
Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer
@nl
prefLabel
Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer
@en
Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer
@nl
P2093
P2860
P50
P356
P1476
Risk of second malignant neoplasms among long-term survivors of testicular cancer
@en
P2093
B A Kohler
E A Clarke
E Holowaty
F E Van Leeuwen
J F Fraumeni
J Sturgeon
K Bergfeldt
P2860
P304
P356
10.1093/JNCI/89.19.1429
P407
P577
1997-10-01T00:00:00Z